- Published at
- by seekingalpha.com
positive
positive
Alcon’s Tryptyr Adds Growth, But Valuation Keeps Shares On 'Hold' (NYSE:ALC)
Alcon posts steady growth in Vision Care and Surgical, with new drug and therapy launches ahead but execution risks persist. Read why ALC stock is a hold.